SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-048606
Filing Date
2021-12-16
Accepted
2021-12-16 16:30:17
Documents
2
Period of Report
2021-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1548
2 EX-24 DOCUMENT attachment1.htm EX-24 3994
  Complete submission text file 0000899243-21-048606.txt   6976
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Issuer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONSTELLATION PHARMACEUTICALS, INC. 215 FIRST STREET, SUITE 200 CAMBRIDGE MA 02142
Business Address
Humphrey Jeffrey (Reporting) CIK: 0001816944 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40499 | Film No.: 211498132